Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
460 JPY | +2.45% | +0.66% | -20.42% |
May. 09 | StemRIM to Seek Shareholders' Approval on Capital Stock Reduction | MT |
Mar. 13 | StemRIM Announces Initiation of Phase 2 Clinical Trial for Redasemtide in Ischemic Cardiomyopathy | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.42% | 176M | |
-2.02% | 89.01B | |
-3.68% | 37.79B | |
-14.91% | 31.22B | |
+60.33% | 26.1B | |
-22.74% | 14.25B | |
-8.73% | 12.8B | |
-10.57% | 11.65B | |
+4.04% | 8.7B | |
-15.32% | 7.45B |
- Stock Market
- Equities
- 4599 Stock
- News StemRIM
- StemRIM Discloses Issuance Details of Stock Options to Directors